TTOO(Delisted)
T2 BiosystemsยทNASDAQ
--
--(--)
TTOO Profile
T2 Biosystems, Inc.
A leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes
101 Hartwell Avenue, Lexington, Massachusetts 02421
--
T2 Biosystems, Inc., was established on April 27, 2006. The company is an in vitro diagnostic company and a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The company's technology enables rapid detection of pathogens, biomarkers and abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets within detection limits as low as one colony-forming unit per milliliter, or CFU/mL. The company is currently targeting a range of healthcare diseases that are considered severely underserved, with an initial focus on those diseases where rapid detection may enable faster targeted antimicrobial therapy, improve patient outcomes and reduce costs.
